A Pilot Study of Oncaspar® + Dexamethasone in Patients With Relapsed or Refractory T-Cell Lymphoma
Clinical trial NCT01878708 · TERMINATED
Trial details
- NCT number
- NCT01878708
- Sponsor
- Dana-Farber Cancer Institute
- Status
- TERMINATED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-01
- Primary completion
- 2017-02-01
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.